InspireMD, Inc. — Director's Dealing 2025

Jan 10, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: InspireMD, Inc. (NSPR)
CIK: 0001433607
Period of Report: 2025-01-07

Reporting Person: Slosman Marvin (Director, CEO and President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-01-07	Restricted Stock Units	A	558417	—	Acquired	2410536	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-01-07	Options to purchase common stock (right to buy)	$2.71	A	254985	Acquired	2035-01-07	Common Stock (254985)	Direct

Footnotes

F1: These restricted stock units vest and become exercisable in three equal annual installments, with 1/3 vesting on each of January 07, 2026, January 7, 2027 and January 7, 2028, subject to the Reporting Person's continued service.

F2: The options vest and become exercisable in three equal installments, with 1/3 vesting on each of January 07, 2026, January 7, 2027 and January 7, 2028, subject to the Reporting Person's continued service.